I've been monitoring the CGTX stock recently and noticed a significant decline in its price. I'm wondering what factors might have contributed to this downward trend.
6 answers
TaekwondoPower
Thu Dec 05 2024
Cognition Therapeutics has experienced a significant decline in its stock price.
SakuraBloom
Thu Dec 05 2024
The drop amounts to 43% following the release of trial results.
Caterina
Thu Dec 05 2024
The trial was conducted on CT1812, the company's lead candidate for treating Alzheimer's disease.
JejuSunshineSoul
Wed Dec 04 2024
CT1812 is specifically designed for patients with mild to moderate Alzheimer's.
GliderPulse
Wed Dec 04 2024
Unfortunately, the results did not show any clinically significant change.